Preexisting TP53-Variant Clonal Hematopoiesis and Risk of Secondary Myeloid Neoplasms in Patients With High-grade Ovarian Cancer Treated With Rucaparib - Kwan, T T; Oza, A M; Tinker, A V (JAMA Oncol, 2021)